Free Trial

Ultragenyx Pharmaceutical (RARE) Insider Trading & Ownership

Ultragenyx Pharmaceutical logo
$23.90 +0.64 (+2.76%)
As of 02:13 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Ultragenyx Pharmaceutical (NASDAQ:RARE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$3.29M
Get RARE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ultragenyx Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RARE Insider Buying and Selling by Quarter

Ultragenyx Pharmaceutical Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/18/2026
Shehnaaz Suliman
Director
Sell5,740$25.12$144,188.80  
5/5/2026Sell344$24.96$8,586.24  
5/1/2026Sell4,683$24.90$116,606.70  
4/1/2026Sell4,683$20.97$98,202.51  
3/3/2026Sell1,635$22.40$36,624.00  
3/3/2026Buy$22.07$1,001 - $15,000
3/2/2026Sell54,404$22.80$1,240,411.20  
3/2/2026Sell7,029$22.80$160,261.20  
3/2/2026Sell10,539$22.80$240,289.20  
3/2/2026Sell8,409$22.70$190,884.30  
3/2/2026Sell10,029$22.80$228,661.20  
3/2/2026Sell8,135$22.80$185,478.00  
3/2/2026Sell1,632$22.80$37,209.60  
2/18/2026Buy$20.45$1,001 - $15,000
2/2/2026Sell3,061$23.56$72,117.16  
12/29/2025Sell85$34.38$2,922.30  
12/10/2025Sell3,081$36.38$112,086.78  
10/13/2025Sell7,942$31.51$250,252.42  
9/18/2025Sell64$29.17$1,866.88  
9/12/2025Sell2,450$31.17$76,366.50  
8/8/2025Buy$27.54$1,001 - $15,000
7/15/2025Buy$27.20$1,001 - $15,000
6/20/2025Sell2,405$37.39$89,922.95  
(Data available from 1/1/2013 forward)

RARE Insider Trading Activity - Frequently Asked Questions

5.20% of Ultragenyx Pharmaceutical stock is owned by insiders. Learn more on RARE's insider holdings.

The following insiders have sold RARE shares in the last 24 months: Corazon (Corsee) D Sanders ($185,245.97), Emil D Kakkis ($8,423,263.81), Eric Crombez ($197,748.86), Erik Harris ($240,289.20), Howard Horn ($1,342,741.27), John Richard Pinion ($836,543.10), Karah Herdman Parschauer ($831,325.70), Shehnaaz Suliman ($144,188.80), Theodore Alan Huizenga ($87,822.77), and Thomas Richard Kassberg ($253,778.80).

Insiders have sold a total of 341,438 Ultragenyx Pharmaceutical shares in the last 24 months for a total of $12,542,948.28 sold.

Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of Ultragenyx Pharmaceutical in the last year totaling $32,000.



This page (NASDAQ:RARE) was last updated on 5/29/2026 by MarketBeat.com Staff.
From Our Partners